Literature DB >> 10725539

A fluorescence based non-radioactive electrophoretic mobility shift assay.

K Ruscher1, M Reuter, D Kupper, G Trendelenburg, U Dirnagl, A Meisel.   

Abstract

Electrophoretic mobility shift assay (EMSA) or gel shift assay is one of the most powerful methods for studying protein-DNA interactions. Typically, 32P-labeled DNA probes containing the sequence bound by the protein of interest are used in EMSA (rEMSA). Although rEMSA is sensitive and practicable, it relies on the handling of hazardous radioisotopes, and does not easily allow quantification. We developed a non-radioactive procedure using fluorescence (Cyano dye Cy5) labeled oligodeoxynucleotide duplexes as specific probes (fEMSA) and an automatic DNA sequencer for analysis. Testing different DNA-binding proteins (restriction endonuclease EcoRII, transcription factor NFkappaB and it's subunit p50) the results in fEMSA and rEMSA are similar in regard to quality, reproducibility, and sensitivity. fEMSA allows a semiquantitative screening of large amounts of samples for specific DNA binding activities and is, therefore, a high throughput technology for semiquantitative analysis of DNA-protein interaction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725539     DOI: 10.1016/s0168-1656(00)00207-8

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  14 in total

1.  Non-independence of Mnt repressor-operator interaction determined by a new quantitative multiple fluorescence relative affinity (QuMFRA) assay.

Authors:  T K Man; G D Stormo
Journal:  Nucleic Acids Res       Date:  2001-06-15       Impact factor: 16.971

2.  Selective glutaraldehyde-mediated coupling of proteins to the 3'-adenine terminus of polymerase chain reaction products.

Authors:  John G Bruno; Randy Crowell
Journal:  J Biomol Tech       Date:  2008-07

3.  Using FAM labeled DNA oligos to do RNA electrophoretic mobility shift assay.

Authors:  Kun Wang; Ya Gao; Xiaojue Peng; Guohua Yang; Feng Gao; Shaoqing Li; Yingguo Zhu
Journal:  Mol Biol Rep       Date:  2009-09-26       Impact factor: 2.316

4.  An Improved Method for Identifying Specific DNA-Protein-Binding Sites In Vitro.

Authors:  Liangyan Wang; Huizhi Lu; Yunguang Wang; Su Yang; Hong Xu; Kaiying Cheng; Ye Zhao; Bing Tian; Yuejin Hua
Journal:  Mol Biotechnol       Date:  2017-03       Impact factor: 2.695

5.  An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides.

Authors:  Yi-Wen Hsieh; Amel Alqadah; Chiou-Fen Chuang
Journal:  J Vis Exp       Date:  2016-11-29       Impact factor: 1.355

6.  A Pit-1 Binding Site Adjacent to E-box133 in the Rat PRL Promoter is Necessary for Pulsatile Gene Expression Activity.

Authors:  Sudeep Bose; Surajit Ganguly; Sachin Kumar; Fredric R Boockfor
Journal:  Neurochem Res       Date:  2016-02-15       Impact factor: 3.996

7.  Counting CAG repeats in the Huntington's disease gene by restriction endonuclease EcoP15I cleavage.

Authors:  Elisabeth Möncke-Buchner; Stefanie Reich; Merlind Mücke; Monika Reuter; Walter Messer; Erich E Wanker; Detlev H Krüger
Journal:  Nucleic Acids Res       Date:  2002-08-15       Impact factor: 16.971

8.  Neuronal nitric oxide synthase is a key factor in doxorubicin-induced toxicity to rat-isolated cortical neurons.

Authors:  Miguel Angelo Lopes; Andreas Meisel; Félix Dias Carvalho; Maria de Lourdes Bastos
Journal:  Neurotox Res       Date:  2009-11-19       Impact factor: 3.911

9.  Quantitative, solution-phase profiling of multiple transcription factors in parallel.

Authors:  Betul Bilgin; Li Liu; Christina Chan; S Patrick Walton
Journal:  Anal Bioanal Chem       Date:  2013-01-30       Impact factor: 4.142

10.  ER stress-inducible factor CHOP affects the expression of hepcidin by modulating C/EBPalpha activity.

Authors:  Susana J Oliveira; Jorge P Pinto; Gonçalo Picarote; Vera M Costa; Félix Carvalho; Maria Rangel; Maria de Sousa; Sérgio F de Almeida
Journal:  PLoS One       Date:  2009-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.